Fusion of transformed human cells by simian retroviruses. NLM AIDSLINE Important note: Information in this article was accurate in 1981. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Fusion of transformed human cells by simian retroviruses.

Gann. 1980 Jun;71(3):367-71. Unique Identifier : AIDSLINE MED/81024883
Ogura H; Tanaka T; Ocho M; Namba M; Oda T; Yabe Y


Abstract: Mason-Pfizer monkey virus (MPMV), baboon endogenous virus (BaEV) and simian sarcoma virus associated virus (SSAV) induced fusion in cultured human cells derived from tumors or transformed in vitro. Not only virus-transformed cells, but also cells transformed spontaneously by 4-nitroquinoline 1-oxide (4-NQO) treatment or by 60Co-gamma ray irradiation were fused by these simian retroviruses. Non-transformed cells derived from normal human embryos were not fused by any of these viruses. Of these tumor or transformed cells, cells carrying Rous sarcoma virus (RSV) genome were most extensively fused by these simian retroviruses. Anti-MPMV, anti-BaEV and anti-SSAV sera blocked the cell fusion mediated by MPMV, BaEV and SSAV, respectively, and not that by other viruses, indicating that the cell fusion was virus-specific.
Keywords: Carcinoma/PATHOLOGY *Cell Fusion Cell Line Cell Transformation, Neoplastic/*PATHOLOGY Cell Transformation, Viral Glioma/PATHOLOGY Human Retroviridae/*GROWTH & DEVELOPMENT Sarcoma Viruses, Avian Sarcoma Viruses, Simian/GROWTH & DEVELOPMENT Support, Non-U.S. Gov't JOURNAL ARTICLEKWDcarcinoma/pathologyKWDcellfusioncelllinecelltransformation,neoplastic/KWDpathologycelltransformation,viralglioma/pathologyhumanretroviridae/KWDgrowth&developmentsarcomaviruses,aviansarcomaviruses,simian/growth&developmentsupport,non-uKWDsKWDgov'tjournalarticle
810228
M8120003

Copyright © 1981 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1981. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1981. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .